Alternatively, the cross-species analysis of C-MYC could guide the development of improved animal models of C-MYC-driven cancer, such as mice expressing human C-MYC protein49, by focusing on adjusting oncogenic C-MYC expression between mammalian models and patient samples. The gene discussed is MYC; the disease is cancer.